Thursday, April 15, 2021
Home Tags Citius

Tag: citius

Citius, Biotech Stock Review
2020 Watch List

Adding Citius Pharma (CTXR) $1.29 to the 2021 Biotech Portfolio.

Editor / Curator -
Biotech News

Where is Citius Pharma (CTXR) in the FDA Approval Process?

Editor / Curator -
Citius Pharma
2020 Watch List

Citius Pharma (CTXR) On The Move.

Editor / Curator -
Superbug News - CoronaVirus Watch List

Citius (CTXR) Trades 13 Million Shares on CoronaVirus and Candida Auris...

Editor / Curator -
Citius, Biotech Stock Review
Biotech News

Citius (CTXR) Achieves 50% Patient Enrollment in Phase 3 Mino-Lok® Pivotal...

Editor / Curator -
steven boyd, biotech stock review
Biotech News

Armistice Capital Master Fund Ltd., and Citius Pharma (CTXR).

Editor / Curator -
candida auris, citius pharma, biotech stock review
Biotech News

Citius Pharma’s (CTXR) Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris.

Editor / Curator -

Latest article

Tiki Hut 7

Seven of the World’s Top Performing Stocks, Every Morning

Uncategorized Editor / Curator -
THE TIKI HUT FUND | TODAY'S 7 BIGGEST MOVERS

Telehealth: iRhythm Technologies, Inc. (IRTC) Opening Down $43 (32%).

All News Editor / Curator -
Let the dust settle or catch the falling knife? Down from a peak of $270, it's been a difficult...
CB Scientific, Biotech Stock Review, Telehealth

My-Cam™ and My-Cardia™ the Ultimate ‘Any-Doctor-Anywhere’ Telehealth Monitoring Application.

Telehealth Editor / Curator -
New and Updated Report on CB Scientific (CBSC) $1.05. Revolutionary Any-Doctor-Any Where, at Home Heart Rate Monitor, can...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.